Pediatric Outcomes and Recovery With Peri-Operative Iron Supplement Evaluation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-18
SponsorUniversity of British Columbia

About this trial

Varus-derotation osteotomy (VDRO) is a surgery to prevent or address hip displacement in children. Many children having this surgery have cerebral palsy or other neuromotor disorders, who have a higher rate of malnutrition, including low iron or anemia. This can affect their surgical outcomes, such as increasing their need for blood transfusions. This project aims to develop a preoperative nutritional program for VDRO patients, to improve their surgical outcomes and decrease their need for transfusions. This may include taking iron supplementation for patient with low iron or anemia. Participants will undergo a nutrition program before their surgery.

Eligibility criteria

Qualifiers

All patients scheduled for VDRO and/or pelvic osteotomy surgery (prospective cohort)

All patients who had VDRO and/or pelvic osteotomy surgery between February 2022 and December 2024 (historical cohort)

Ages 0-18 years old

Disqualifiers

Patients who have undergone a major surgical intervention in the last 3 months

Patients who have received a nutritional intervention that includes iron testing and treatment within the last 3 months

Patients in whom oral/enteral iron supplementation is contraindicated

Patients who have a bleeding disorder

Trial design

Treatments tested in this trial

  • Iron Supplement
  • Comprehensive Nutrition Management

Treatment groups

180 Participants
are divided into 3 treatment groups

Sponsors and collaborators

University of British Columbia

Lead sponsor

BC Children's Hospital Research Institute

Collaborator